Search Results 411-420 of 18133 for Lymphocytic leukemia
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
... Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies ... lymphocytic leukemia. Patients will be randomized 1:1 into the two arms ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. ... lymphocytic leukemia (CLL) in comparison to ...
... lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring ...
... Lymphocytic Leukemia. Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
It's part of the body's germ-fighting immune system. The lymphatic system also includes the spleen, thymus, tonsils, adenoids and bone marrow. Hodgkin lymphoma, ...
This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.